Dose-Response Curve Mapping¶
Model — instantiates Assimilation Ceiling Guarding
Charts the receiver's net response across the full range of input dose, locating the band where more helps and the point where it flips to harm.
The dangerous assumption behind most overload is that the response to an input is monotonic — that if some is good, more is better. Dose-Response Curve Mapping disproves or confirms that assumption by charting the whole shape: it varies the input dose across a range and records the receiver's net response at each level, producing a curve that typically rises, plateaus, and then turns down. Its defining product is two features of that curve — the beneficial range band where net response is positive, and the inversion threshold where it crosses back into harm. Where an audit measures how much the receiver can hold, this maps what happens to output as you push the dose up, including — critically — the doses past the peak, which no forecast ever explores.
Example¶
An agronomist is advising on nitrogen fertilizer. The naïve view is linear: more nitrogen, more yield. Dose-Response Curve Mapping tests it by charting yield against application rate across a wide range of plots. The curve climbs steeply at first, flattens into a plateau, and then bends down — at high rates the crop lodges, salts accumulate, and net yield falls, even before counting the nitrogen leaching off into the watershed. The map hands back two numbers: a beneficial band of roughly 120–160 kg/ha where each added unit still pays, and an inversion point near ≈200 kg/ha past which more fertilizer actively costs yield. Those figures are illustrative, but the shape is the point — it is a hormetic response,[n1] beneficial at low dose and harmful at high, and it means the right answer is a band to stay inside, not a direction to push.
How it works¶
What distinguishes this from a simple capacity estimate is that it interrogates the range, not the operating point:
- Vary the dose across the full range. Sample responses at low, moderate, and — deliberately — supra-optimal doses, so the down-turning arm of the curve is observed rather than assumed away.
- Measure net response at each level. Use an outcome that already nets benefit against the costs the input imposes, so the curve bends where it truly bends.
- Locate the band and the inversion. Read off the beneficial range (net positive) and the inversion threshold (net crosses zero and keeps falling); these, not the average response, are the map's deliverables.
Tuning parameters¶
- Dose range and resolution — how far past the apparent peak to probe, and how finely. Pushing further finds the true inversion but costs real input and risks real harm in the test itself.
- Response metric — a single outcome versus a composite. Mapping one metric (yield) while a hidden cost (soil, runoff) climbs invisibly is the fastest way to a curve that lies.
- Curve model — whether the shape is treated as a sharp threshold or a smooth hormetic bend; the wrong model misplaces the inversion.
- Beneficial cutoff — whether "beneficial" means net-positive or net-above-a-margin; a stricter cutoff narrows the band and pulls the usable ceiling inward.
- Re-mapping cadence — static curve versus periodic re-mapping, since the response shifts as conditions (soil, market, context) change.
When it helps, and when it misleads¶
Its strength is that it makes the nonlinearity visible and refutes "more is better" with evidence: it shows that the peak is not the safe place to operate and that harm accelerates past the inversion. Downstream, the band and threshold are what let a limit or a review know where the edge actually is.
Its failure modes are those of any fitted curve. Extrapolating beyond the tested range invents an inversion point rather than finding it; assuming the curve is stationary ignores that context moves it; and mapping a single metric can certify a dose as "beneficial" while an unmeasured cost is already climbing. The classic misuse is to publish only the rising arm — the part that flatters "invest more" — and quietly omit the turn. The discipline is to probe past the peak, use a composite response, and re-map when the context shifts rather than trusting a curve drawn under conditions that no longer hold.
How it implements the components¶
Dose-Response Curve Mapping is the cartographer of the archetype's benefit curve — it produces the two shape features and nothing else:
beneficial_range_band— the sub-range of dose over which the receiver's net response is positive; the map's core output.inversion_threshold— the dose at which net response flips from benefit to burden, located from the curve's downturn rather than assumed.
It does not size the receiver's absorptive throughput (assimilation_capacity_estimate — that's Assimilation Capacity Audit), and it does not choose the operating setpoint or the margin to keep below the inversion (ceiling_margin_policy — that's Marginal Net-Benefit Review). It draws the map; others decide where on it to stand.
Related¶
- Instantiates: Assimilation Ceiling Guarding — the curve locates the edge that the surrounding guards defend.
- Sibling mechanisms: Marginal Net-Benefit Review · Assimilation Capacity Audit · Input Rate Limit · Cleanup Capacity Reserve · Hysteresis Recovery Protocol · Staged Absorption Gate · Secondary Resource Telemetry · Protected Margin Escalation Rule · Surplus Load Diversion · Overshoot Tabletop Stress Test · Post-Inversion After-Action Review
Editorial Notes¶
Form Classification¶
Form family: Experiment, Test & Rehearsal
Rationale: Dose-Response Curve Mapping operates as a bounded trial, probe, simulation, or rehearsal that generates evidence from performance because it charts the receiver's net response across the full range of input dose, locating the band where more helps and the point where it flips to harm.
Independent corroboration: The frozen evidence defines Dose-Response Curve Mapping as 'Charts the receiver's net response across the full range of input dose, locating the band where more helps and the point where it flips to harm', so its operative form is Experiment, Test & Rehearsal.
Review outcome: Independent reviewer agreement; high confidence.
Origin Attribution¶
Primary origin: Pharmacology & Toxicology
Origin pattern: Single lineage
Present-day reach: Multi-domain
Rationale: Pharmacology and toxicology cohered mapping response across dose to locate efficacy bands, saturation, and harmful or hormetic inversion.
Related originating lineages:
- Biology & Ecology — Ecotoxicology and organismal biology developed dose-response curves for environmental exposures.
- Statistics & Experimental Design — Experimental design supplies controlled dose levels, curve fitting, and uncertainty bands.
Review resolution: Pharmacology and toxicology cohered full-range dose-response mapping; organismal biology and statistical design are genuine co-formative lineages rather than application domains.
Review outcome: Reconciled after independent review; high confidence.
Notes¶
The curve is a map, not a live decision. It says where the beneficial band and the inversion are; it does not say where you are standing right now or whether the last increment paid off — that continuous reading against the map is Marginal Net-Benefit Review, which consumes this curve. Keeping mapping separate from the operating decision is what lets the curve be re-drawn as conditions change without re-arguing every intake choice.
[n1] Hormesis — a biphasic dose-response in which a low dose of an input is beneficial and a high dose of the same input is harmful. It is the canonical benefit-band-with-inversion, and the reason the response must be mapped across the whole range rather than extrapolated from the rising arm. ↩